Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$422M |
| 2 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$411M |
| 3 |
iShares China Large-Cap ETF
FXI
|
+$351M |
| 4 |
Pfizer
PFE
|
+$331M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$319M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.28B |
| 2 |
Meta Platforms (Facebook)
META
|
+$989M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$953M |
| 4 |
Amazon
AMZN
|
+$816M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$782M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 2.06% |
| 2 | Consumer Discretionary | 1.41% |
| 3 | Healthcare | 0.83% |
| 4 | Financials | 0.79% |
| 5 | Industrials | 0.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
11751
PUT
Babcock & Wilcox
BW
$1.12B
| $38.7K | ﹤0.01% |
+26,500
| New | +$56.5K |
|
11752
Solitario Resources
XPL
$76.7M
| $38.1K | ﹤0.01% |
68,074
+42,637
| +168% | +$23K |
|
|
ASXC
11753
DELISTED
Asensus Surgical, Inc.
ASXC
| $38.1K | ﹤0.01% |
119,387
+87,355
| +273% | +$22.5K |
|
11754
CALL
Dragonfly Energy
DFLI
$17.1M
| $38K | ﹤0.01% |
781
-7,530
| -91% | -$571K |
|
11755
CALL
Vertical Aerospace
EVTL
$132M
| $37.9K | ﹤0.01% |
5,490
-6,800
| -55% | -$60.2K |
|
|
NOTV
11756
CALL
DELISTED
Inotiv
NOTV
| $37.8K | ﹤0.01% |
10,300
+200
| +2% | +$505 |
|
|
AKTS
11757
CALL
DELISTED
Akoustis Technologies Inc
AKTS
| $37.7K | ﹤0.01% |
45,400
-20,000
| -31% | -$13.4K |
|
|
GMDA
11758
CALL
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
| $37.7K | ﹤0.01% |
91,900
+5,400
| +6% | +$3.05K |
|
|
TWOU
11759
PUT
DELISTED
2U Inc
TWOU
| $37.3K | ﹤0.01% |
1,010
-357
| -26% | -$17.4K |
|
11760
PRF Technologies Ltd
PRFX
$2.98M
| $37.2K | ﹤0.01% |
+112
| New | +$33.9K |
|
11761
Gogoro
GGR
$54.8M
| $37.1K | ﹤0.01% |
+719
| New | +$37.4K |
|
11762
CALL
Seres Therapeutics
MCRB
$49M
| $37.1K | ﹤0.01% |
1,325
-9,320
| -88% | -$245K |
|
11763
ZK International Group
ZKIN
$72.2M
| $37.1K | ﹤0.01% |
5,349
+2,143
| +67% | +$11.6K |
|
|
SOLO
11764
PUT
DELISTED
Electrameccanica Vehicles Corp. Ltd.
SOLO
| $37.1K | ﹤0.01% |
109,000
-43,200
| -28% | -$18.2K |
|
11765
PUT
Talphera
TLPH
$64.9M
| $37K | ﹤0.01% |
50,000
| – | – |
|
11766
Latham Group
SWIM
$838M
| $37K | ﹤0.01% |
14,058
-20,487
| -59% | -$50.7K |
|
|
SDPI
11767
DELISTED
Superior Drilling Products Inc.
SDPI
| $36.9K | ﹤0.01% |
+51,642
| New | +$37.9K |
|
11768
PUT
China Automotive Systems
CAAS
$158M
| $36.8K | ﹤0.01% |
11,400
-15,000
| -57% | -$51.5K |
|
|
OGI
11769
PUT
Organigram Holdings
OGI
$176M
| $36.7K | ﹤0.01% |
28,000
-3,500
| -11% | -$4.3K |
|
11770
Cue Biopharma
CUE
$195M
| $36.7K | ﹤0.01% |
463
-1,962
| -81% | -$140K |
|
|
11771
Talphera
TLPH
$64.9M
| $36.7K | ﹤0.01% |
49,886
-21,299
| -30% | -$13.6K |
|
|
NIU
11772
Niu Technologies
NIU
$154M
| $36.4K | ﹤0.01% |
16,639
-42,259
| -72% | -$96.7K |
|
|
SVM
11773
CALL
Silvercorp Metals
SVM
$2.89B
| $36.3K | ﹤0.01% |
13,800
-1,024,100
| -99% | -$2.51M |
|
|
MGRM
11774
DELISTED
Monogram Orthopaedics
MGRM
| $36K | ﹤0.01% |
+10,470
| New | +$31.6K |
|
11775
PUT
Protalix BioTherapeutics
PLX
$193M
| $36K | ﹤0.01% |
20,200
-400
| -2% | -$622 |
|
Similar funds
Jeff Yass's Q4 2023 Portfolio in Review
As of Q4 2023, Jeff Yass held 13,823 positions worth $525B, up 9.3% from $481B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Jeff Yass's Q4 2023 filing shows 1,903 new, 5,066 increased, 5,122 reduced and 1,577 closed positions. Its largest new stake was Vanguard Emerging Markets Government Bond ETF: 471,007 shares worth $30M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $4.28B.
By sector, the portfolio is most concentrated in Technology at 2.1% of assets, down from 2.4% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Jeff Yass's largest Q4 2023 buy was Vanguard Emerging Markets Government Bond ETF: 471,007 shares worth $30M.
- Jeff Yass added most to Alibaba in Q4 2023, an estimated $422M increase.
- Jeff Yass's biggest Q4 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $4.28B.
- Jeff Yass fully exited VMware, Inc in Q4 2023, selling an estimated $313M.
- Jeff Yass's ten largest holdings make up 24% of its $525B portfolio in Q4 2023.
- Jeff Yass opened 1,903 new positions and closed 1,577 in Q4 2023.
- Jeff Yass's portfolio value rose 9.3% quarter-over-quarter to $525B.
Based on Susquehanna International Group's 13F filing for Q4 2023, filed 14 Feb 2024.